FIELD: medicine.
SUBSTANCE: invention relates to chemical-pharmaceutical industry, namely to creation of medication for treatment and prevention of oncologic diseases. Medication represents tabletted form and contains calcium carbonate, vitamin D3, zinc oxide, Ca41Cl2 with induced activity 0.1 microcurie, vitamin E.
EFFECT: medication has anti-tumour action, increases efficiency of oncologic disease treatment.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATMENT AND PREVENTION OF ONCOLOGIC DISEASES AND METHOD OF APPLICATION SAID AGENT (VERSIONS) | 2008 |
|
RU2377007C1 |
| PHARMACEUTICAL FORMULATION FOR METASTASIS PREVENTION AND INCREASING OF TUMOUR SENSITISATION TO CHEMOTHERAPEUTIC AGENTS | 2007 |
|
RU2328282C1 |
| METHOD FOR PREDICTING AND TREATING MASTOPATHY | 2004 |
|
RU2280407C2 |
| FOODSTUFF KIT FOR WEEKLY DIET FOR ONCOLOGY PATIENTS AND LONG-LIVERS | 2005 |
|
RU2286679C1 |
| METHODS FOR COMBINED THERAPY OF MALIGNANT NEOPLASMS USING IRON OXIDE NANOPARTICLES | 2023 |
|
RU2816227C1 |
| RADIOTHERAPEUTIC PARTICLES AND SUSPENSIONS | 2016 |
|
RU2770073C2 |
| METHOD FOR PREPARING PHARMACEUTICALLY ACCEPTABLE DOSAGE FORMS AND USING THEM IN COMBINED CHEMOTHERAPY AND PHOTODYNAMIC THERAPY OF MALIGNANT NEOPLASMS | 2023 |
|
RU2822629C1 |
| METHOD OF TREATING PALMAR-PLANTAR ERYTHRODYSESTHESIA | 2018 |
|
RU2722396C2 |
| MUSHROOMS PRODUCTION METHOD | 2016 |
|
RU2689951C1 |
| COMBINED APPLICATION OF EPA, DPA AND DHA WITH CHEMOTHERAPEUTIC AGENT | 2012 |
|
RU2637406C2 |
